Company Overview of Quintiles Consulting, Inc.
Quintiles Consulting, Inc. provides global regulatory, compliance, and validation consulting services to pharmaceutical, biotechnology, and medical device industries. The company offers strategic regulatory consulting in the areas of quality systems development and optimization, FDA enforcement solutions, validation, and bioresearch monitoring. In addition, it provides global strategies and services for medical device development, including pre-clinical services, clinical trial development and management, reimbursement, and the United States and European Union submissions. The company is based in Vernon Hills, Illinois. Quintiles Consulting, Inc. operates as a subsidiary of Quintiles Transna...
935 Lakeview Parkway
Vernon Hills, IL 60061
Key Executives for Quintiles Consulting, Inc.
President of Clinical Development
Managing Director of Regulatory & Quality Practice and Vice President of Regulatory & Quality Practice
Head of the Quality Systems
Compensation as of Fiscal Year 2013.
Quintiles Consulting, Inc. Key Developments
Sinclair IS Pharma plc and Quintiles Consulting, Inc. Sign 10-Year Collaboration and Licensing Agreement
Sep 13 12
Sinclair IS Pharma plc and Quintiles Consulting, Inc. announced the signing of a 10-year collaboration and licensing agreement for Quintiles (Rowfarma Mexico) to commercialise Sinclair IS's portfolio of dermo-cosmetic products and medical devices in Mexico. Under the agreement, Quintiles will handle the entire process including regulatory submissions; product importation, warehousing and distribution to wholesalers; sales force promotion to dermatologists and plastic surgeons; and marketing, advertising and promotion. The Sinclair IS portfolio consists of the following products: Atopiclair® for the treatment of mild to moderate atopic dermatitis; Kelo-cote® silicone-gel scar reduction range for the prevention and management of abnormal scars; Sebclair® for the treatment of seborrhoeic dermatitis; Bio-Taches® for hyperpigmentation disorders; XClair® for the treatment of radiation dermatitis; and Papulex® for the management and maintenance of mild to moderate acne.
Quintiles Consulting, Inc. Introduces Allume, Comprehensive Go-to-Market Service
Jul 10 12
Quintiles Consulting, Inc. introduced Allume, a comprehensive go-to-market service to help biopharmaceutical companies efficiently launch new products and shorten timelines to peak sales, while retaining strategic and corporate control of their assets. Allume simplifies and organizes the complex and resource-intensive launch planning process; provides unique data-driven insights from 15 years of market entry experience across the globe and taps Quintiles' local market and therapeutic category expertise. A unique combination of Consulting, Clinical and Commercial expertise, paired with software, Allume incorporates Quintiles' years of biopharma product launch experience into flexible, seamless support that complements in-house capabilities. It can be fully customized to each company and product to help identify key market challenges, fast-track launch rollout and improve efficiency in resource management. This cost-effective solution allows companies to benefit from Quintiles' product lifecycle expertise rather than assume the financial risk of creating their own infrastructure to support launch planning early in the commercialization process.
American Diabetes Association to Collaborate with Quintiles' Digital Patient Unit
Apr 4 12
Quintiles Consulting, Inc. and the American Diabetes Association announced a strategic agreement in which Quintiles' Digital Patient Unit will provide the Association's millions of website users access to Quintiles' medication monitoring service. The Association's constituents who opt in for the service will receive free safety checks of their medications to identify potential interactions and other risk factors.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|